LIMN

Liminatus Pharma

• TipRanks·08/24 12:05

  Liminatus Pharma engages Synex Consulting to support IBC101 development

• TipRanks·08/20 23:50

  Liminatus Pharma Inc trading halted, news pending

• NASDAQ·08/19 07:02

  Liminatus Pharma Announces 1-for-50 Reverse Stock Split; Stock Down

• TipRanks·08/18 20:31

  Liminatus Pharma Enacts Reverse Split to Maintain Listing

• Seeking Alpha·08/18 20:17

  Liminatus Pharma sets 1-for-50 reverse split; stock drops in after hours

• TipRanks·08/18 20:10

  Liminatus Pharma announces 1-for-50 reverse stock split

• Dow Jones·08/18 20:02

  *Liminatus Pharma Board Approves Reverse Stk Split at Ratio of 1-for-50 >LIMN

• TipRanks·08/13 18:11

  Liminatus Pharma (LIMN) Stock Jumps Over 50% on a Listing Update

• NASDAQ·08/13 12:46

  Liminatus Pharma Transfers To Nasdaq Capital Market; Shares Surge In Pre-Market

• TipRanks·08/04 21:37

  Liminatus Pharma Shareholders Approve Reverse Stock Split Plan

• TipRanks·07/30 10:29

  Liminatus Pharma Reports Improved Nasdaq Listing Compliance Status

• TipRanks·07/24 21:18

  Liminatus Pharma Faces Nasdaq Delisting Risk, Plans Reverse Split

• TipRanks·07/16 13:00

  Why is Cathie Wood’s ARK Fund Backing this Israeli Innovator? (NASDAQ: MDWD)

• TipRanks·07/06 13:27

  Liminatus Pharma Closes InnocsAI Merger and Share Issuance

• NASDAQ·07/01 07:06

  Liminatus Pharma Amends Merger Agreement With InnocsAI To Expand Oncology Pipeline